🇺🇸 FDA
Pipeline program

Phenoxybenzamine

PRESCRIPT2010.369

Approved small_molecule completed

Quick answer

Phenoxybenzamine for Pheochromocytoma is a Approved program (small_molecule) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Atrium Therapeutics
Indication
Pheochromocytoma
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials